Short-Term Anticoagulation After Cardioversion in New-Onset Atrial Fibrillation and Low Thromboembolic Risk: A Real-World International Investigation

Short-Term Anticoagulation After Cardioversion in New-Onset Atrial Fibrillation and Low Thromboembolic Risk: A Real-World International Investigation

<i>Background and Objectives</i>: International guidelines differ on short-term (4-week) oral anticoagulation (OAC) indication after acute cardioversion for recent-onset atrial fibrillation (AF < 12–48 h) in low-risk patients (CHA<sub>2</sub>DS<sub>2</sub>-VA =...

Full description

Saved in:
Bibliographic Details
Main Authors: Alan Poggio, Andrew P. Sullivan, Lorenzo Rampa, Jason G. Andrade, Matteo Anselmino
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Medicina
Subjects:
atrial fibrillation
cardioversion
short-term oral anticoagulation
thromboembolism
stroke
bleeding
Online Access:https://www.mdpi.com/1648-9144/61/7/1200
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1648-9144/61/7/1200

Similar Items